You have 9 free searches left this month | for more free features.

Measurement of C11-Acetate uptake in tumors which are often non-FDG avid.

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • FDG PET/CT scan
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Jan 10, 2023

History of Myocardial Infarction Trial in Boston (18F-FDG PET/CT)

Recruiting
  • History of Myocardial Infarction
  • 18F-FDG PET/CT
  • Boston, Massachusetts
    Massachusetts General Hospital, Havard Medical School
Nov 30, 2021

Prostate Cancer Patients Trial in Philadelphia (11C-Acetate)

Completed
  • Prostate Cancer Patients
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
May 12, 2022

NSCLC, Immune Checkpoint Inhibitors Trial in Seoul (F-18 FDG PET/CT)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Immune Checkpoint Inhibitors
  • F-18 FDG PET/CT
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 15, 2022

Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)

Not yet recruiting
  • Hypercholesterolemia
  • +3 more
  • Cambridge, United Kingdom
    University of Cambridge
Jan 13, 2023

Advanced Cancer Trial in New York (FDG)

Suspended
  • Advanced Cancer
  • FDG
  • New York, New York
    Weill Medical College of Cornell University
Jan 28, 2022

PET Imaging of Giant Cell and Takayasu Arteritis

Active, not recruiting
  • Giant Cell Arteritis
  • Takayasu Arteritis
  • PET-MRI
  • Cambridge, Cambridgeshire, United Kingdom
  • +1 more
Jul 31, 2022

Endometrial Cancer, Ovarian Cancer Trial in Sherbrooke (Loperamide Pill, hyoscine-n-butylbromide)

Recruiting
  • Endometrial Cancer
  • Ovarian Cancer
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Oct 31, 2022

Prosthetic Valve Endocarditis Trial in Paris (FDG-PET at the end of treatment for IE)

Not yet recruiting
  • Prosthetic Valve Endocarditis
  • FDG-PET at the end of treatment for IE
  • Paris, France
    Hôpital Bichat-Claude Bernard
Aug 2, 2023

Neuroendocrine Tumors Trial in Toronto (F18-FDG)

Recruiting
  • Neuroendocrine Tumors
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 20, 2022

PET-CT Predicting Segement Specific Lymph Nodes Metastasis

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Shanghai, China
      Shanghai Cancer Center
    Jul 23, 2023

    Type 2 Diabetes, Cardiovascular Risk Factor Trial in Catanzaro (Empagliflozin 10 MG, Glimepiride 2 mg)

    Completed
    • Type 2 Diabetes
    • Cardiovascular Risk Factor
    • Empagliflozin 10 MG
    • Glimepiride 2 mg
    • Catanzaro, Italy
      Universital Hospital Mater Domini
    Jan 14, 2023

    Acetoacetate and Acetate Metabolism in Chronic Kidney

    Not yet recruiting
    • Kidney Failure, Chronic
    • PET scan metabolic day
    • (no location specified)
    Jul 20, 2023

    NSCLC Trial in Iowa City ([18F]F-ARAG PET)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • [18F]F-ARAG PET
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Oct 10, 2023

    Lymph Node Metastases by NF-PanNENs

    Recruiting
    • Non Functioning Pancreatic Endocrine Tumor
      • Milan, Italy
        IRCCS San Raffaele Hospital
      Aug 23, 2022

      Neuroendocrine Tumors Trial in Edmonton (18F-DOPA with furosemide)

      Not yet recruiting
      • Neuroendocrine Tumors
      • 18F-DOPA with furosemide
      • Edmonton, Alberta, Canada
        University of Alberta Hospital
      May 23, 2022

      PET Tracer Based FDG Signal for Predicting Prognosis in Acute

      Enrolling by invitation
      • Acute Myeloid Leukemia
      • No intervention
      • Guangzhou, Guangdong, China
        First Affiliated Hospital of Jinan University
      Jun 22, 2023

      Non-Hodgkin Lymphoma Trial in Dallas (Focal radiation therapy (RT))

      Recruiting
      • Non-Hodgkin Lymphoma
      • Focal radiation therapy (RT)
      • Dallas, Texas
        UT Southwestern Medical Center
      Jul 8, 2022

      PET/CT, FAPI, Oral Cancer Trial in Wuhan (68Ga-DOTA-FAPI, PET/CT)

      Recruiting
      • PET/CT
      • +2 more
      • Wuhan, Hubei, China
        Zhongnan Hopital of Wuhan University
      Dec 30, 2021

      Pheochromocytoma, Paraganglioma Trial in Marseille (Infrared themrography)

      Recruiting
      • Pheochromocytoma
      • Paraganglioma
      • Infrared themrography
      • Marseille, Paca, France
        Pôle ENDO- Hopital la Conception APHM
      Nov 12, 2022

      Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)

      Not yet recruiting
      • Glioma
      • +4 more
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Oct 3, 2022

      FDG PET/CT in Breast Cancer Bone Mets

      Active, not recruiting
      • Estrogen Receptor Positive Breast Cancer
      • Bone Metastases
      • FDG PET/CT scan
      • Philadelphia, Pennsylvania
        University of Pennsylvania Hospital
      Oct 13, 2022

      Ultrasound and PET/CT in Diagnosis and Monitoring of Giant Cell

      Completed
      • Giant Cell Arteritis
      • Vasculitis
      • Ultrasound
      • (no location specified)
      Oct 1, 2021

      68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor:Pragmatic Study

      Recruiting
      • Solid Cancers
      • [68Ga]-PSMA-617
      • Sherbrooke, Quebec, Canada
        CHUS
      Mar 15, 2022

      PET Avidity in Cachexia-Inducing Lung and Gastrointestinal

      Active, not recruiting
      • Cachexia; Cancer
      • Retrospective study
      • Dallas, Texas
        UT Southwestern Medical Centre
      Apr 27, 2022